Dr Reddys Laboratories (RDY) Change in Intangibles (2024 - 2025)

Dr Reddys Laboratories (RDY) recorded quarterly Change in Intangibles of -$56.3 million in Q3 2025, down 46.67% quarter-over-quarter from -$38.4 million in Q2 2025, and down 1164.54% on a YoY basis from $5.3 million in Q3 2024.

Dr Reddys Laboratories (RDY) Change in Intangibles (2024 - 2025) Analysis & Trends

Dr Reddys Laboratories' Change in Intangibles history runs 2 years deep, the most recent figure standing at -$56.3 million for Q3 2025.

  • In Q3 2025, Change in Intangibles fell 1164.54% year-over-year to -$56.3 million; the TTM figure through Sep 2025 stood at -$114.9 million (changed N/A YoY), while the FY2026 annual figure was -$171.1 million, down 109.73% from the prior year.
  • Change in Intangibles was -$56.3 million for Q3 2025 at Dr Reddys Laboratories, down from -$38.4 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of -$4.5 million in Q3 2024 to a low of -$56.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -56.31 Mn
Sep 30, 2025 -56.31 Mn
Jun 30, 2025 -38.40 Mn
Jun 30, 2025 -38.40 Mn
Sep 30, 2024 -4.45 Mn
Sep 30, 2024 -4.45 Mn
Jun 30, 2024 -15.75 Mn
Jun 30, 2024 -15.75 Mn